Hemodynamic Parameters in People With Atherosclerotic Vascular Disease Referred to a Secondary Prevention and Cardiovascular Rehabilitation Program (NCT06701032)
Evolution of Hemodynamic Parameters in People With Atherosclerotic Vascular Disease Referred to a Secondary Prevention and Cardiovascular Rehabilitation (PREV) Program: a Prospective Cohort Study.
🩺 Plain-English Summary (8th-Grade Level)
The main purpose of this study is to evaluate the hemodynamic changes in the forefoot of patients with coronary, cerebrovascular or peripheral atherosclerotic disease referred a 12-week cardiovascular rehabilitation program (PREV program). Also, this study will describe the characteristics of patients admitted to the PREV program and their evolutions in terms of favorable, unfavorable outcomes and complications and up to one year after completion of the program.
Who can join: Review the eligibility criteria below.
Location: CLSC de Lévis - Programme PREV du CISSS de Chaudière-Appalaches — Lévis, Quebec
Age range: 18 Years
🧪 Interventions in This Study
- Cardiovascular rehabilitation program (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- CLSC de Lévis - Programme PREV du CISSS de Chaudière-Appalaches — Lévis, Quebec
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Peripheral Artery Disease (PAD)
- The Chocolate Touch Study — Gainesville, Florida
- Detecting Peripheral Artery Disease With the Pulse — Omaha, Nebraska
- Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease — Alexander City, Alabama
- Using Near-Infrared Light to Better Understand Peripheral Artery Disease — Arlington, Texas
- Serranator POINT FORCE Registry — Scottsdale, Arizona
Explore by condition: All Peripheral Artery Disease (PAD) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.